Literature DB >> 11368430

International Childhood Acute Lymphoblastic Leukemia Workshop: Sausalito, CA, 30 November-1 December 2000.

C H Pui1, S Sallan, M V Relling, G Masera, W E Evans.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11368430     DOI： 10.1038/sj.leu.2402111

Source DB:  PubMed          Journal:  Leukemia        ISSN： 0887-6924            Impact factor:   11.528


× No keyword cloud information.
  5 in total

Review 1.  International collaboration on childhood leukemia.

Authors:  Ching-Hon Pui; Raul C Ribeiro
Journal:  Int J Hematol       Date:  2003-12       Impact factor: 2.490

2.  Transplant Outcomes for Children with T Cell Acute Lymphoblastic Leukemia in Second Remission: A Report from the Center for International Blood and Marrow Transplant Research.

Authors:  Michael J Burke; Michael R Verneris; Jennifer Le Rademacher; Wensheng He; Hisham Abdel-Azim; Allistair A Abraham; Jeffery J Auletta; Mouhab Ayas; Valerie I Brown; Mitchell S Cairo; Ka Wah Chan; Miguel A Diaz Perez; Christopher C Dvorak; R Maarten Egeler; Lamis Eldjerou; Haydar Frangoul; Gregory M T Guilcher; Robert J Hayashi; Ahmed Ibrahim; Kimberly A Kasow; Wing H Leung; Richard F Olsson; Michael A Pulsipher; Niketa Shah; Nirali N Shah; Elizabeth Thiel; Julie-An Talano; Carrie L Kitko
Journal:  Biol Blood Marrow Transplant       Date:  2015-08-29       Impact factor: 5.742

3.  Survival differences between adolescents/young adults and children with B precursor acute lymphoblastic leukemia after allogeneic hematopoietic cell transplantation.

Authors:  Michael J Burke; Nathan Gossai; John E Wagner; Angela R Smith; Veronika Bachanova; Qing Cao; Margaret L MacMillan; Heather S Stefanski; Daniel J Weisdorf; Michael R Verneris
Journal:  Biol Blood Marrow Transplant       Date:  2012-09-06       Impact factor: 5.742

4.  Clinical and laboratory evaluation of compliance in acute lymphoblastic leukaemia.

Authors:  B M de Oliveira; M B Viana; C L Zani; A J Romanha
Journal:  Arch Dis Child       Date:  2004-08       Impact factor: 3.791

5.  Between-course targeting of methotrexate exposure using pharmacokinetically guided dosage adjustments.

Authors:  Jennifer L Pauley; John C Panetta; Kristine R Crews; Deqing Pei; Cheng Cheng; John McCormick; Scott C Howard; John T Sandlund; Sima Jeha; Raul Ribeiro; Jeffrey Rubnitz; Ching-Hon Pui; William E Evans; Mary V Relling
Journal:  Cancer Chemother Pharmacol       Date:  2013-06-13       Impact factor: 3.333
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.